R
Rebecca Jones
Researcher at University of Manchester
Publications - 151
Citations - 9440
Rebecca Jones is an academic researcher from University of Manchester. The author has contributed to research in topics: Placenta & Decidua. The author has an hindex of 49, co-authored 146 publications receiving 8227 citations. Previous affiliations of Rebecca Jones include University of Edinburgh & Prince Henry's Institute of Medical Research.
Papers
More filters
Journal ArticleDOI
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
Sarah J. Tabrizi,Rachael I. Scahill,Alexandra Durr,Raymund A.C. Roos,Blair R. Leavitt,Rebecca Jones,G. Bernhard Landwehrmeyer,Nick C. Fox,Hans J. Johnson,Stephen Hicks,Christopher Kennard,David Craufurd,Chris Frost,Douglas R. Langbehn,Ralf Reilmann,Julie C. Stout +15 more
TL;DR: The Track-HD study as discussed by the authors examined disease progression in premanifest individuals carrying the mutant HTT gene and those with early stage disease and reported 12-month longitudinal changes, building on baseline findings.
Journal ArticleDOI
Cytokines, chemokines and growth factors in endometrium related to implantation
TL;DR: This review focuses on those cytokines and chemokines whose expression pattern in the human endometrium is consistent with a potential role in implantation and placentation and for which some relevant actions are known.
Journal ArticleDOI
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
Sarah J. Tabrizi,R Reilmann,Raymond A. C. Roos,Alexandra Durr,Blair R. Leavitt,Gail Owen,Rebecca Jones,Hans J. Johnson,David Craufurd,Stephen Hicks,Christopher Kennard,Bernhard Landwehrmeyer,Julie C. Stout,Beth Borowsky,Rachael I. Scahill,Chris Frost,Douglas R. Langbehn +16 more
TL;DR: On the basis of longitudinal effect size, several objective outcome measures for clinical trials in participants with early HD are recommended and Hypothetical treatment effects defined by slower longitudinal changes in these measures would be detectable over a realistic timescale with practical sample sizes.
Journal ArticleDOI
Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy.
TL;DR: It is confirmed that vascular remodeling occurs in distinct trophoblast-independent and -dependent stages and provided the first evidence of decidual leukocyte involvement in trophoblasts-independent stages.
Journal ArticleDOI
Advanced maternal age and adverse pregnancy outcomes: A systematic review and meta-analysis.
Samantha C. Lean,Samantha C. Lean,Hayley Derricott,Rebecca Jones,Rebecca Jones,Alexander E. P. Heazell,Alexander E. P. Heazell +6 more
TL;DR: It is proposed that placental dysfunction may mediate adverse pregnancy outcome in AMA and stillbirth risk increases with increasing maternal age, not wholly explained by maternal co-morbidities and use of ART.